REGENERON PHARMACEUTICALS, INC. (REGN) SEC Filings & Financial Intelligence
REGENERON PHARMACEUTICALS, INC. (REGN) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: REGN
CIK: 872589
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: NY
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerSonia Luaces
Audit LocationFlorham Park, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-11-06 | 2026-11-04 | PRIMARY DOCUMENT | 0002009236-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-11-05 | 2026-11-03 | PRIMARY DOCUMENT | 0001796226-26-000004 | View SEC Doc Filr Page |
| 13F-HR | 2026-11-05 | 2026-09-30 | 13F-HR Filing | 0001104659-26-123321 | View SEC Doc Filr Page |
| 4 | 2026-11-05 | 2026-11-03 | PRIMARY DOCUMENT | 0001681643-26-000008 | View SEC Doc Filr Page |
| 144 | 2026-11-04 | — | 144 Filing | 0001968582-26-001101 | View SEC Doc Filr Page |
| 4 | 2026-11-04 | 2026-11-02 | PRIMARY DOCUMENT | 0001225471-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-11-04 | 2026-11-02 | PRIMARY DOCUMENT | 0001189014-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-11-04 | 2026-11-02 | PRIMARY DOCUMENT | 0001697422-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-11-04 | 2026-11-02 | PRIMARY DOCUMENT | 0001238303-26-000004 | View SEC Doc Filr Page |
| 144 | 2026-11-04 | — | 144 Filing | 0001969223-26-001125 | View SEC Doc Filr Page |
| 4 | 2026-11-03 | 2026-10-30 | PRIMARY DOCUMENT | 0001992352-26-000009 | View SEC Doc Filr Page |
| 144 | 2026-11-03 | — | 144 Filing | 0001969223-26-001124 | View SEC Doc Filr Page |
| 4 | 2026-11-03 | 2026-10-30 | PRIMARY DOCUMENT | 0001174475-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-11-03 | 2026-10-30 | PRIMARY DOCUMENT | 0001663758-26-000004 | View SEC Doc Filr Page |
| 144 | 2026-11-02 | — | 144 Filing | 0001958244-26-000681 | View SEC Doc Filr Page |
| 144 | 2026-11-02 | — | 144 Filing | 0001950047-26-010543 | View SEC Doc Filr Page |
| 144 | 2026-11-02 | — | 144 Filing | 0001969223-26-001114 | View SEC Doc Filr Page |
| 144 | 2026-10-30 | — | 144 Filing | 0001950047-26-010507 | View SEC Doc Filr Page |
| 144 | 2026-10-30 | — | 144 Filing | 0001969223-26-001109 | View SEC Doc Filr Page |
| 144 | 2026-10-30 | — | 144 Filing | 0001969223-26-001108 | View SEC Doc Filr Page |
| 10-Q | 2026-10-30 | 2026-09-30 | 10-Q | 0000872589-26-000034 | View SEC Doc Filr Page |
| 8-K | 2026-10-30 | 2026-10-30 | 8-K | 0000872589-26-000032 | View SEC Doc Filr Page |
| 4 | 2026-10-15 | 2026-10-13 | PRIMARY DOCUMENT | 0001796226-26-000002 | View SEC Doc Filr Page |
| 144 | 2026-10-14 | — | 144 Filing | 0001969223-26-001073 | View SEC Doc Filr Page |
| 8-K | 2026-10-06 | 2026-10-01 | FORM 8-K | 0001104659-26-113895 | View SEC Doc Filr Page |